PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience

J Endocrinol Invest. 2023 Oct;46(10):2185-2188. doi: 10.1007/s40618-023-02063-x. Epub 2023 Mar 18.

E Monti^#¹, S Gay^#^{1

2}, M Dono³, M Giusti¹, S Pigozzi^{4

5}, G De Luca⁶, G Anselmi⁴, M Mora⁴, B Spina⁴, M N Minuto^{7

5}, M Albertelli¹, F Gatto^{1

2}, D Ferone^{1

2}

¹ Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DI.M.I.), University of Genoa, 16132, Genoa, Italy.
² Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
³ Molecular Diagnostic Unit, IRCCS Ospedale Policlinico San Martino, L.go R. Benzi, 10, 16132, Genoa, Italy. [email protected].
⁴ Department of Pathology, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
⁵ Department of Surgical Sciences (DISC), University of Genova, 16132, Genoa, Italy.
⁶ Molecular Diagnostic Unit, IRCCS Ospedale Policlinico San Martino, L.go R. Benzi, 10, 16132, Genoa, Italy.
⁷ General Surgery Unit 1, Department of Surgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

^# Contributed equally.

No abstract available

MeSH terms